Watch "An Update on the Clinical Studies Using Arimoclomol as a Potential Treatment for sIBM" with Dr. Mazen Dimachkie,...
The primary focus of Myositis Support and Understanding is muscle diseases which are referred to as “Idiopathic Inflammatory Myopathies” or “Acquired Myopathies,” meaning muscle diseases which are typically not inherited and are caused by the immune system attacking muscles, connective tissue, blood vessels, and/or the skin.
Identification of Predictors for Interstitial Lung Disease in Myositis Patients: A Systematic Review
![](https://understandingmyositis.org/wp-content/uploads/avatars/18/5c26225d19e4a-bpthumb.png)
Interstitial lung disease (ILD) is a well-recognized complication in the spectrum of diseases known as the idiopathic inflammatory myopathies...
RDMD and MSU Collaborating for IBM Research
![](https://understandingmyositis.org/wp-content/uploads/avatars/18/5c26225d19e4a-bpthumb.png)
We are excited to announce a new collaboration with RDMD, a company that aims to jumpstart research for patients...
DETERMINE - a Phase 3 trial designed to evaluate the efficacy and safety of lenabasum for the treatment of adults...
The first step when approaching a patient with muscle weakness – Differential diagnosis of idiopathic inflammatory myopathies in adults
![](https://understandingmyositis.org/wp-content/uploads/avatars/18/5c26225d19e4a-bpthumb.png)
Information on the differential diagnosis of adults with muscle weakness. Differential diagnosis is the process of distinguishing a specific...
Corbus launches DETERMINE, a Phase 3 trial of lenabasum for the treatment of dermatomyositis
![](https://understandingmyositis.org/wp-content/uploads/avatars/18/5c26225d19e4a-bpthumb.png)
New locations announced July 9, 2019. DETERMINE is a double-blind, placebo-controlled 1-year study designed to test the efficacy and...
Myositis and Cancer: Risk highest for carriers of anti-TIF1 antibody
![](https://understandingmyositis.org/wp-content/uploads/avatars/18/5c26225d19e4a-bpthumb.png)
The research found that DM patients with the anti-transcriptional intermediary factor 1 (anti-TIF1) antibody were more than three times...
New Classification System for Idiopathic Inflammatory Myopathies, phenotypes
![](https://understandingmyositis.org/wp-content/uploads/avatars/18/5c26225d19e4a-bpthumb.png)
The authors propose that a new classification system for Idiopathic Inflammatory Myopathies (IIM) based on phenotypic (observable characteristics), biologic...
Advances in the Early Diagnosis and Therapy of Inclusion Body Myositis
![](https://understandingmyositis.org/wp-content/uploads/avatars/18/5c26225d19e4a-bpthumb.png)
The purpose of this article is to describe advancements in the diagnosis of Inclusion Body Myositis (IBM) and therapy...
The information collected by ultrasound elastography (USE), such as structural changes of muscle, is thought to make it useful for...
Statin Use Associated with Idiopathic Inflammatory Myopathies
![](https://understandingmyositis.org/wp-content/uploads/avatars/18/5c26225d19e4a-bpthumb.png)
Statins are drugs that lower cholesterol. There have been reports indicating that statin use may be associated with idiopathic...
New Study for Patients with Inclusion Body Myositis (IBM) at Yale
![](https://understandingmyositis.org/wp-content/uploads/avatars/18/5c26225d19e4a-bpthumb.png)
We would like to let you know about a clinical research study that is available for patients diagnosed with...
MSU’s guest author, Dr. Daniel Chellete, analyzed recent studies concerning exercise with Myositis. Dr. Chellete is a doctor of...
"New Developments on the Role of Itch in Dermatomyositis", based on new research published in the British Journal of...
New Insights on sporadic Inclusion body myositis (sIBM) pathogenesis
![](https://understandingmyositis.org/wp-content/uploads/avatars/18/5c26225d19e4a-bpthumb.png)
Dr. Conrad "Chris" Weihl joins MSU live for a session titled "New Insights on sporadic Inclusion body myositis (sIBM)...
Polymyositis: The evolution of this diagnosis in light of recent research
![](https://understandingmyositis.org/wp-content/uploads/avatars/18/5c26225d19e4a-bpthumb.png)
Watch "Polymyositis: The evolution of this diagnosis in light of recent research" with Dr. Christopher-Stine, who also discusses immune-mediated...
The NT5C1A Antibody Test and its Role in the Diagnosis of Inclusion Body Myositis
![](https://understandingmyositis.org/wp-content/uploads/avatars/18/5c26225d19e4a-bpthumb.png)
Learn more about the NT5CIA antibody and its association with inclusion body myositis from Dr. Kevin Dooley, a retired...
PR: MSU, Portable Genomics teaming up to bring a tailored health data management platform to myositis patients
![](https://understandingmyositis.org/wp-content/uploads/avatars/18/5c26225d19e4a-bpthumb.png)
Portable Genomics and Myositis Support and Understanding Association (MSU) have partnered to enable myositis patients to better collect, manage,...
Corbus Pharmaceuticals will host Jerry Williams, the Founder and President of MSU, Heather Spadaccini, Jerry’s friend and part-time caregiver,...
Explaining myositis (Idiopathic Inflammatory Myopathy) and how it affects our lives is difficult. There isn’t a simple, clear-cut answer...